Literature DB >> 18511468

Ontologizer 2.0--a multifunctional tool for GO term enrichment analysis and data exploration.

Sebastian Bauer1, Steffen Grossmann, Martin Vingron, Peter N Robinson.   

Abstract

UNLABELLED: The Ontologizer is a Java application that can be used to perform statistical analysis for overrepresentation of Gene Ontology (GO) terms in sets of genes or proteins derived from an experiment. The Ontologizer implements the standard approach to statistical analysis based on the one-sided Fisher's exact test, the novel parent-child method, as well as topology-based algorithms. A number of multiple-testing correction procedures are provided. The Ontologizer allows users to visualize data as a graph including all significantly overrepresented GO terms and to explore the data by linking GO terms to all genes/proteins annotated to the term and by linking individual terms to child terms. AVAILABILITY: The Ontologizer application is available under the terms of the GNU GPL. It can be started as a WebStart application from the project homepage, where source code is also provided: http://compbio.charite.de/ontologizer. REQUIREMENTS: Ontologizer requires a Java SE 5.0 compliant Java runtime engine and GraphViz for the optional graph visualization tool.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18511468     DOI: 10.1093/bioinformatics/btn250

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  231 in total

1.  geWorkbench: an open source platform for integrative genomics.

Authors:  Aris Floratos; Kenneth Smith; Zhou Ji; John Watkinson; Andrea Califano
Journal:  Bioinformatics       Date:  2010-05-28       Impact factor: 6.937

2.  Schizophrenia and vitamin D related genes could have been subject to latitude-driven adaptation.

Authors:  Roberto Amato; Michele Pinelli; Antonella Monticelli; Gennaro Miele; Sergio Cocozza
Journal:  BMC Evol Biol       Date:  2010-11-11       Impact factor: 3.260

3.  Ribosomal protein genes are highly enriched among genes with allele-specific expression in the interspecific F1 hybrid catfish.

Authors:  Ailu Chen; Ruijia Wang; Shikai Liu; Eric Peatman; Luyang Sun; Lisui Bao; Chen Jiang; Chao Li; Yun Li; Qifan Zeng; Zhanjiang Liu
Journal:  Mol Genet Genomics       Date:  2016-01-08       Impact factor: 3.291

4.  Dynamics of Hippocampal Protein Expression During Long-term Spatial Memory Formation.

Authors:  Natalia Borovok; Elimelech Nesher; Yishai Levin; Michal Reichenstein; Albert Pinhasov; Izhak Michaelevski
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

5.  Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis.

Authors:  Navin Rauniyar; Kanagaraj Subramanian; Mathieu Lavallée-Adam; Salvador Martínez-Bartolomé; William E Balch; John R Yates
Journal:  Mol Cell Proteomics       Date:  2015-04-14       Impact factor: 5.911

6.  Optimization criteria and biological process enrichment in homologous multiprotein modules.

Authors:  Luqman Hodgkinson; Richard M Karp
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-11       Impact factor: 11.205

7.  A probabilistic model of neutral and selective dynamics of protein network evolution.

Authors:  Janusz Dutkowski; Jerzy Tiuryn
Journal:  J Comput Biol       Date:  2013-08-09       Impact factor: 1.479

8.  Reconstructing dynamic microRNA-regulated interaction networks.

Authors:  Marcel H Schulz; Kusum V Pandit; Christian L Lino Cardenas; Namasivayam Ambalavanan; Naftali Kaminski; Ziv Bar-Joseph
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-28       Impact factor: 11.205

9.  UVB-induced gene expression in the skin of Xiphophorus maculatus Jp 163 B.

Authors:  Kuan Yang; Mikki Boswell; Dylan J Walter; Kevin P Downs; Kimberly Gaston-Pravia; Tzintzuni Garcia; Yingjia Shen; David L Mitchell; Ronald B Walter
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2014-02-17       Impact factor: 3.228

10.  Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.

Authors:  Edit Porpaczy; Sabrina Tripolt; Andrea Hoelbl-Kovacic; Bettina Gisslinger; Zsuzsanna Bago-Horvath; Emilio Casanova-Hevia; Emmanuelle Clappier; Thomas Decker; Sabine Fajmann; Daniela A Fux; Georg Greiner; Sinan Gueltekin; Gerwin Heller; Harald Herkner; Gregor Hoermann; Jean-Jacques Kiladjian; Thomas Kolbe; Christoph Kornauth; Maria-Theresa Krauth; Robert Kralovics; Leonhard Muellauer; Mathias Mueller; Michaela Prchal-Murphy; Eva Maria Putz; Emmanuel Raffoux; Ana-Iris Schiefer; Klaus Schmetterer; Christine Schneckenleithner; Ingrid Simonitsch-Klupp; Cathrin Skrabs; Wolfgang R Sperr; Philipp Bernhard Staber; Birgit Strobl; Peter Valent; Ulrich Jaeger; Heinz Gisslinger; Veronika Sexl
Journal:  Blood       Date:  2018-06-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.